Joana Melo, Co-Founder and COO of NU-RISE, will be attending ABS 2026 in Los Angeles. If you are interested in in vivo dosimetry, treatment verification, HDR brachytherapy quality assurance, or learning more about the FDA-cleared PRO-DOSE system, NU-RISE would be delighted to meet with you during the conference. Let's discuss clinical implementation, workflow integration, research collaborations, and the future of treatment verification in HDR brachytherapy.
Schedule a Meeting at ABS 2026